These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 3802553
1. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease. Steel NR, Taylor JJ, Young ET, Farndon JR, Holcombe M, Kendall-Taylor P. Clin Endocrinol (Oxf); 1987 Jan; 26(1):97-106. PubMed ID: 3802553 [Abstract] [Full Text] [Related]
2. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Maugendre D, Massart C. Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931 [Abstract] [Full Text] [Related]
3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related]
4. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A. Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255 [Abstract] [Full Text] [Related]
5. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid. Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK. Autoimmunity; 1990 Oct; 8(2):143-7. PubMed ID: 1983330 [Abstract] [Full Text] [Related]
6. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. Mori Y, Matoba N, Miura S, Sakai N, Taira Y. World J Surg; 1992 Oct; 16(4):647-52; discussion 652-3. PubMed ID: 1357830 [Abstract] [Full Text] [Related]
8. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [Abstract] [Full Text] [Related]
9. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG. Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965 [Abstract] [Full Text] [Related]
10. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment. Tamai H, Hirota Y, Kasagi K, Matsubayashi S, Kuma K, Iida Y, Konishi J, Okimura MC, Walter RM, Kumagai LF. J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520 [Abstract] [Full Text] [Related]
11. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T. J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399 [Abstract] [Full Text] [Related]
12. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K. J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248 [Abstract] [Full Text] [Related]
13. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment]. Uno C, Nishikawa M. Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):206-15. PubMed ID: 2456230 [Abstract] [Full Text] [Related]
14. Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM, Smith BR. Clin Endocrinol (Oxf); 1982 Jun 20; 16(6):537-43. PubMed ID: 6125279 [Abstract] [Full Text] [Related]
18. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease. Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J. Clin Endocrinol (Oxf); 1988 Oct 20; 29(4):357-66. PubMed ID: 2908031 [Abstract] [Full Text] [Related]
19. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism. Hörmann R, Hobelsberger A, Saller B, Mann K. Klin Wochenschr; 1986 Oct 31; 64(21):1097-100. PubMed ID: 2879958 [Abstract] [Full Text] [Related]
20. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin. Mukuta T, Tamai H, Oshima A, Morita T, Matsubayashi S, Fukata S, Kuma K. Clin Endocrinol (Oxf); 1994 Feb 31; 40(2):215-9. PubMed ID: 7907955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]